Amarin to Present at Two Upcoming Investor Conferences
02 June 2023 - 6:30AM
Amarin Corporation plc (NASDAQ:AMRN) today announced that Aaron
Berg, Amarin’s Interim President and Chief Executive Officer and
Tom Reilly, Amarin’s Chief Financial Officer, will present at two
upcoming investor conferences:
Jefferies
Healthcare Conference (June 7-9, 2023; New York, New
York)
Date/Time: |
June 7, 2023, 8:00 a.m. ET |
Webcast: |
https://wsw.com/webcast/jeff281/amrn/1850420 |
|
|
Goldman Sachs
44th Annual Global Healthcare Conference (June
12-15, 2023; Dana Point, California)
Date/Time: |
June 12, 2023, 5:40 p.m. ET/2:40 p.m. PDT |
Webcast: |
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fcc.webcasts.com%2fgold006%2f061223a_js%2f%3fentity%3d71_KJRLSOQ&c=E,1,U7tqzyzZ9xuUF2nvJKkai8nOvaIiSzq6FuiyHNDNe9DwG-FksiDRG68O_8nYUoHfLbMkV8sjTlscCZXNh_Hc_8SdRvY9B53FcNTzzKLX_hb-rzEAhVsp&typo=1 |
Both conference presentations will be webcast
live and archived on the Company’s website in the Investor
Relations section under Events and Presentations at Events |
Amarin Corporation plc.
About AmarinAmarin is an innovative
pharmaceutical company leading a new paradigm in cardiovascular
disease management. From our foundation in scientific research to
our focus on clinical trials, and now our commercial expansion, we
are evolving and growing rapidly. Amarin has offices in
Bridgewater, New Jersey in the United States, Dublin in Ireland,
Zug in Switzerland, and other countries in Europe as well as
commercial partners and suppliers around the world. We are
committed to increasing the scientific understanding of the
cardiovascular risk that persists beyond traditional therapies and
advancing the treatment of that risk.
Availability of Other Information About
AmarinAmarin communicates with its investors and the
public using the company website (www.amarincorp.com) and the
investor relations website (investor.amarincorp.com), including but
not limited to investor presentations and FAQs, Securities and
Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on these
channels and websites could be deemed to be material information.
As a result, Amarin encourages investors, the media and others
interested in Amarin to review the information that is posted on
these channels, including the investor relations website, on a
regular basis. This list of channels may be updated from time to
time on Amarin’s investor relations website and may include social
media channels. The contents of Amarin’s website or these channels,
or any other website that may be accessed from its website or these
channels, shall not be deemed incorporated by reference in any
filing under the Securities Act of 1933.
Amarin Contact InformationInvestor
Inquiries:Lisa DeFrancescoAmarin Corporation
plcIR@amarincorp.com Media Inquiries:Mark MarmurAmarin
Corporation plcPR@amarincorp.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Apr 2024 to May 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From May 2023 to May 2024